SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-239062
Filing Date
2020-09-03
Accepted
2020-09-03 16:20:58
Documents
14
Period of Report
2020-09-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d45106d8k.htm   iXBRL 8-K 25657
2 EX-99.1 d45106dex991.htm EX-99.1 47546
6 GRAPHIC g45106g0903212959385.jpg GRAPHIC 5199
  Complete submission text file 0001193125-20-239062.txt   218300

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20200903.xsd EX-101.SCH 3075
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20200903_lab.xml EX-101.LAB 18839
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20200903_pre.xml EX-101.PRE 11842
7 EXTRACTED XBRL INSTANCE DOCUMENT d45106d8k_htm.xml XML 3885
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 201159494
SIC: 2834 Pharmaceutical Preparations